VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 10, 2008) - Pyng Medical Corp. (TSX VENTURE: PYT) today announced it has completed the acquisition of the trauma assets of California-based Bio Cybernetics International (BCI) (dba “Cybertech Medical”, www.cybertechmedical.com), including the market leading Trauma Pelvic Orthotic Device (TPOD®), Mechanical Advantage Tourniquet (MAT®), and Cricothyrotomy Kit (CRIC™). As previously announced, the purchase price was $US 2.4 million, part paid on closing and part subject to achievement of certain milestones. Pyng has received final regulatory approval for this transaction from the TSX Venture Exchange.
